Related Experiment Videos
p53 gene mutation and expression in naevi and melanomas
L E Sparrow1, R Soong, H J Dawkins
1Department of Pathology, University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands.
Melanoma Research
|April 1, 1995
Summary
p53 protein expression increases with melanoma progression, even without gene mutations. This suggests other factors influence p53 levels in skin cancer, impacting tumor development.
Area of Science:
- Oncology
- Molecular Biology
- Dermatopathology
Background:
- Mutations in the p53 tumor suppressor gene are frequent in many cancers.
- While increased p53 expression is noted in cutaneous malignant melanoma, p53 gene mutations are infrequent.
- Understanding p53's role in melanoma is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate p53 protein expression and mutation status in benign and malignant melanocytic lesions.
- To correlate p53 expression levels with tumor progression and depth of invasion.
- To explore mechanisms influencing p53 protein expression in melanoma.
Main Methods:
- Immunohistochemistry using anti-p53 antibody DO-7 on 140 melanocytic lesions.
- Microwave antigen retrieval technique for enhanced immunoreactivity.
- PCR-SSCP analysis of p53 gene exons 5-8 in selected lesions.
Main Results:
- p53 protein expression was detected in 33% of naevi, 35% of primary melanomas, and 70% of metastatic melanomas.
- Expression intensity and cellular staining increased with melanoma progression and depth of invasion.
- p53 gene mutations were found in 25% of metastatic melanomas but not in benign lesions.
Conclusions:
- Antigen retrieval techniques enhance p53 detection in melanocytic tissues.
- p53 protein expression, not solely gene mutations, correlates with melanoma progression.
- Alternative mechanisms likely regulate p53 protein levels in melanocytic lesions.